Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, November 28, 2022
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
[ Mon, Nov 28th 2022
] - WOPRAI
Ed Arce Maintained (UNCY) at Strong Buy with Decreased Target to $8 on, Nov 28th, 2022
Ed Arce of HC Wainwright & Co., Maintained "Unicycive Therapeutics, Inc." (UNCY) at Strong Buy with Decreased Target from $9 to $8 on, Nov 28th, 2022.
Ed, nor any peers, have made any analyst calls on UNCY in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30